My watch list
my.bionity.com  
Login  
NEWS
Current news

Evotec and Celgene enter into strategic oncology partnership

22-May-2018 Evotec AG announced that Evotec and Celgene Corporation have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology. Evotec has built one of the industry's broadest and most innovative pre-clinical discovery and development pla ... more

Pierre Fabre and Roche extend collaboration agreement on companion diagnostic development

22-May-2018 Pierre Fabre announced today the extension of a collaboration agreement with Roche on companion diagnostic development for W0101, Pierre Fabre's new antibody drug conjugate (ADC) product candidate targeting Insulin-like Growth Factor 1 (IGF-1) receptor currently in the international Phase I ... more

PhoreMost completes $15M Series-A round to enter drug discovery

Investment to fund expansion of operations and progression of drug target pipeline

22-May-2018 PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has completed an £11m ($15m) Series-A investment round. The investment will be used to expand operations on the Babraham Research Campus and progress several novel drug ... more

Metal-based probes for detection of dopamine receptors, a cancer biomarker

Discovery can be potentially developed as a novel early cancer detection technology

22-May-2018 A team led by Dr Edmond Ma Dik-lung, Associate Professor of the Department of Chemistry of Hong Kong Baptist University (HKBU) has developed the world's first iridium(III)-based probes for imaging dopamine receptors in living cells. The discovery has enhanced the understanding of dopamine r ... more

Merck and Washington University working on diagnostics and treatment of malnutrition

Genome editing to be used in intestinal bacteria research

22-May-2018 Merck announced a collaboration with Washington University in St. Louis, Missouri, USA, that could lead to the optimizing of nutritional supplements to restore a healthy gut microbial community (microbiome). The two-year collaboration will employ Merck’s CRISPR genome-editing technology in ... more

ZEISS: High-Tech Drives Growth

Medical technology and industrial metrology business still on track for growth

18-May-2018 The first six months of fiscal year 2017/18 (ended 31 March 2018) were successful for the ZEISS Group and saw its revenue rise by 9 percent to EUR 2.773 billion (1st six months of 2016/17: EUR 2.550 billion), and as much as 13 percent after adjustments for currency effects. At EUR 380 milli ... more

A new way to stimulate cellular recycling process

18-May-2018 Brown University researchers studying the biology of aging have demonstrated a new strategy for stimulating autophagy, the process by which cells rebuild themselves by recycling their own worn-out parts. In a study the researchers show that the approach increased the lifespans of worms and ... more

Tiny 'antenna' tweaked on cells

18-May-2018 Scientists at Johns Hopkins Medicine and the National Tsing Hua University in Taiwan say they have found a fast way to manipulate a cell's cilia, the tiny, fingerlike protrusions that "feel" and sense their microscopic environment. The experiments, performed in mouse cells, may advance scie ... more

Genes that helps prevent brain disease

18-May-2018 Scientists know that faulty proteins can cause harmful deposits or "aggregates" in neurological disorders such as Alzheimer's and Parkinson's disease. Although the causes of these protein deposits remain a mystery, it is known that abnormal aggregates can result when cells fail to transmit ... more

Key enzyme for production of second-generation ethanol discovered in Brazilian Amazon

17-May-2018 Second-generation ethanol (also called cellulosic ethanol) open perspectives for optimizing alcohol production. Since 2G ethanol is obtained from from sugarcane straw and bagasse, it basically makes it possible converting waste into energy. Holder of the world's best biomass and boasting th ... more

All news

ZEISS: High-Tech Drives Growth

Medical technology and industrial metrology business still on track for growth

18-May-2018 The first six months of fiscal year 2017/18 (ended 31 March 2018) were successful for the ZEISS Group and saw its revenue rise by 9 percent to EUR 2.773 billion (1st six months of 2016/17: EUR 2.550 billion), and as much as 13 percent after adjustments for currency effects. At EUR 380 milli ... more

A new way to stimulate cellular recycling process

18-May-2018 Brown University researchers studying the biology of aging have demonstrated a new strategy for stimulating autophagy, the process by which cells rebuild themselves by recycling their own worn-out parts. In a study the researchers show that the approach increased the lifespans of worms and ... more

Genes that helps prevent brain disease

18-May-2018 Scientists know that faulty proteins can cause harmful deposits or "aggregates" in neurological disorders such as Alzheimer's and Parkinson's disease. Although the causes of these protein deposits remain a mystery, it is known that abnormal aggregates can result when cells fail to transmit ... more

Flowing cells in a wavy microchannel for effective size-based cell sorting

17-May-2018 Nearly half a century ago scientists have noticed an interesting phenomenon that small particles flowing through a long tube can stay at a specific position along the cross-section of a tube. This is known as inertial focusing. Later, along with the development of microfluidic technology in ... more

Stone age hepatitis B virus decoded

Viral DNA shows the hepatitis B virus has been circulating in Europe for at least 7.000 years

14-May-2018 An international team of scientists led by researchers at Kiel University in the scope the CRC 1266 “Scales of Transformation” and the Max Planck Institute for the Science of Human History has successfully reconstructed genomes from Stone Age and Medieval European strains of the hepatitis B ... more

Discovery of how HIV hedges its bets opens the door to new therapies

14-May-2018 A stem cell is one with infinite possibilities. So, for decades, scientists have puzzled over how the cell chooses to keep being a stem cell and continue dividing, or specialize into a specific cell type, like a heart or brain cell. The same type of decision is made by HIV. When the virus i ... more

New tool analyzes disease and drug effects with unprecedented accuracy and consistency

14-May-2018 A new protein analysis tool developed at the University at Buffalo could vastly increase the speed and precision with which disease and drug effects are analyzed. The groundbreaking tool, called IonStar, is the first to provide near-perfect accuracy when quantifying and comparing the abunda ... more

Eurofins acquires German pharma quality service company

09-May-2018 Eurofins Scientific announces that it has signed an exclusive agreement to acquire PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH (“PHAST”), one of Europe’s leading service providers in the field of pharmaceutical products quality. The transaction is expected to close in the ... more

AI detects patterns of gut microbes for cholera risk

09-May-2018 Researchers from Duke University, Massachusetts General Hospital and the International Centre for Diarrheal Disease Research in Dhaka, Bangladesh have used machine learning algorithms to spot patterns within communities of bacteria living in the human gut that no human would ever be able to ... more

Direct optical reading of single-molecule DNA bases in modified nanopores

Unique combination of SERS and nanopore fluidics

08-May-2018 imec describes a new concept for direct identification of single DNA bases. The technique has the potential to detect, with an unprecedented spatial resolution and without any labeling, the genetic code, as well as epigenetic variations in DNA. The combination of nanopore fluidics and surfa ... more

All news on bioanalytics

PhoreMost completes $15M Series-A round to enter drug discovery

Investment to fund expansion of operations and progression of drug target pipeline

22-May-2018 PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has completed an £11m ($15m) Series-A investment round. The investment will be used to expand operations on the Babraham Research Campus and progress several novel drug ... more

Metal-based probes for detection of dopamine receptors, a cancer biomarker

Discovery can be potentially developed as a novel early cancer detection technology

22-May-2018 A team led by Dr Edmond Ma Dik-lung, Associate Professor of the Department of Chemistry of Hong Kong Baptist University (HKBU) has developed the world's first iridium(III)-based probes for imaging dopamine receptors in living cells. The discovery has enhanced the understanding of dopamine r ... more

Merck and Washington University working on diagnostics and treatment of malnutrition

Genome editing to be used in intestinal bacteria research

22-May-2018 Merck announced a collaboration with Washington University in St. Louis, Missouri, USA, that could lead to the optimizing of nutritional supplements to restore a healthy gut microbial community (microbiome). The two-year collaboration will employ Merck’s CRISPR genome-editing technology in ... more

A new way to stimulate cellular recycling process

18-May-2018 Brown University researchers studying the biology of aging have demonstrated a new strategy for stimulating autophagy, the process by which cells rebuild themselves by recycling their own worn-out parts. In a study the researchers show that the approach increased the lifespans of worms and ... more

Tiny 'antenna' tweaked on cells

18-May-2018 Scientists at Johns Hopkins Medicine and the National Tsing Hua University in Taiwan say they have found a fast way to manipulate a cell's cilia, the tiny, fingerlike protrusions that "feel" and sense their microscopic environment. The experiments, performed in mouse cells, may advance scie ... more

Genes that helps prevent brain disease

18-May-2018 Scientists know that faulty proteins can cause harmful deposits or "aggregates" in neurological disorders such as Alzheimer's and Parkinson's disease. Although the causes of these protein deposits remain a mystery, it is known that abnormal aggregates can result when cells fail to transmit ... more

Key enzyme for production of second-generation ethanol discovered in Brazilian Amazon

17-May-2018 Second-generation ethanol (also called cellulosic ethanol) open perspectives for optimizing alcohol production. Since 2G ethanol is obtained from from sugarcane straw and bagasse, it basically makes it possible converting waste into energy. Holder of the world's best biomass and boasting th ... more

Flowing cells in a wavy microchannel for effective size-based cell sorting

17-May-2018 Nearly half a century ago scientists have noticed an interesting phenomenon that small particles flowing through a long tube can stay at a specific position along the cross-section of a tube. This is known as inertial focusing. Later, along with the development of microfluidic technology in ... more

Enzyme's movement may be key to new cancer drugs

17-May-2018 Revealing all the steps required to activate an enzyme called a protein kinase may identify new ways to target cancer, according to new University of Arizona-led research. Not only must the kinase have all needed parts in place, the enzyme must move in the correct manner and at the correct ... more

Even low concentrations of silver can foil wastewater treatment

17-May-2018 Research at Oregon State University has shed new light how an increasingly common consumer product component - silver nanoparticles - can potentially interfere with the treatment of wastewater. The findings suggest conventional toxicity testing methods for silver concentrations at treatment ... more

All news on biotechnology

Metal-based probes for detection of dopamine receptors, a cancer biomarker

Discovery can be potentially developed as a novel early cancer detection technology

22-May-2018 A team led by Dr Edmond Ma Dik-lung, Associate Professor of the Department of Chemistry of Hong Kong Baptist University (HKBU) has developed the world's first iridium(III)-based probes for imaging dopamine receptors in living cells. The discovery has enhanced the understanding of dopamine r ... more

Malaria detectable in olfactory cocktail

17-May-2018 ETH researchers have discovered odour profiles typical of people infected with acute or asymptomatic malaria. This is a first promising step towards a low-cost diagnostic test that can be used in the field in developing countries. Malaria is still a deadly disease in tropical and subtropica ... more

RNA molecules predict adverse heart growth and function that can lead to atrial fibrillation

16-May-2018 Researchers have identified that enlargement of the left atrium of the heart is linked to abnormal activity of molecules that are associated with adverse changes in the heart's size, shape, structure, and function -- conditions that can lead to atrial fibrillation and death. The new study, ... more

How signals get inside cancer cells and spur aggressive growth

15-May-2018 The outside of a cancer cell is bombarded by signals. They come from the immune system, supporting tissues and other structures. But how do those signals impact cancer? A new study provides a surprising model of the process by which those signals enter and influence the cell. The finding co ... more

Social context matters in spread of disease

09-May-2018 "Patient zero" isn't entirely to blame when an infection takes root in a population. According to Rice University scientists, social context in the community has a lot to do with how a disease spreads. Rice researchers who study fruit flies found that the ratio of females to males as well a ... more

Discovery of a protein linked to metastasis in breast cancer

08-May-2018 Jean-François Côté, a researcher at the Montreal Clinical Research Institute (IRCM) and professor at Université de Montréal's Faculty of Medicine, studies metastasis, the leading cause of cancer-related death. Recently, his team uncovered a protein that, once deactivated, could prevent the ... more

Nanoscale measurements 100x more precise, thanks to improved two-photon technique

08-May-2018 Technique uses photons, fundamental components of light, to measure nanoscopic materials thinner than 100,000th the width of a human hair - with 30,000 fired per second and 500bn throughout Research will mean measurements 100x more precise than existing two-photon techniques - with the pote ... more

Tracing cerebral cortex evolution, cell by cell

Molecular atlases of turtle and lizard brains shed light on the evolution of our own brain

07-May-2018 Our cerebral cortex, a sheet of neurons, connections and circuits, comprises “ancient” regions such as the hippocampus and “new” areas such as the six-layered “neocortex”, found only in mammals and most prominently in humans. But when in evolution did the components of cerebral cortex arise ... more

New technique could bring earlier diagnoses for muscular dystrophy, ALS and similar disorders

07-May-2018 A new blood test could reveal the genetic roots of muscular dystrophy, amyotrophic lateral sclerosis and other disorders caused by the expansion of DNA repeats, potentially helping doctors diagnose their patients’ conditions sooner. The findings by University of Florida Health researchers a ... more

Indications of Psychosis Appear in Cortical Folding

27-Apr-2018 Imaging techniques can be used to detect the development of psychosis in the brains of high-risk patients at an early stage, as reported by researchers from the University of Basel and Western University in the journal JAMA Psychiatry. Detecting psychosis early increases the chances of effe ... more

All news on diagnostics

Tiny 'antenna' tweaked on cells

18-May-2018 Scientists at Johns Hopkins Medicine and the National Tsing Hua University in Taiwan say they have found a fast way to manipulate a cell's cilia, the tiny, fingerlike protrusions that "feel" and sense their microscopic environment. The experiments, performed in mouse cells, may advance scie ... more

Flowing cells in a wavy microchannel for effective size-based cell sorting

17-May-2018 Nearly half a century ago scientists have noticed an interesting phenomenon that small particles flowing through a long tube can stay at a specific position along the cross-section of a tube. This is known as inertial focusing. Later, along with the development of microfluidic technology in ... more

Greiner Bio-One acquires 3D Cell Culture Technology assets from Nano3D Biosciences

15-May-2018 Greiner Bio-One North America, Inc. has acquired 3D Cell Culture Technology previously owned by Nano 3D Biosciences, Inc. As an international distributor of these products since 2016, Greiner Bio-One has now taken the initiative to become a premier provider of this technology worldwide. Mag ... more

Eppendorf continues to generate growth above the market average

Stronger strategic investments for further sustainable growth

27-Apr-2018 The Eppendorf Group can look back at 2017 as a very satisfactory business year.  With Group sales of €690.3 million (prior year: €651.5 million), the company generated growth of 6.0% (organic growth in local currencies: +7.9%) while the world market grew by around 5%. As expected, income fr ... more

Sartorius starts off fiscal 2018 successfully

Exchange rate effects dampen profit growth

24-Apr-2018 Sartorius looks back on a successful first quarter 2018. "Both divisions started off the year strongly in line with our expectations and further increased their revenues in the first quarter of 2018 in all regions. On the currency side, however, we faced some headwinds, especially due to th ... more

Peptide induces chirality evolution in a single gold nanoparticle

20-Apr-2018 For the first time, scientists have successfully created optically active, chiral gold nanoparticles using amino acids and peptides. Many chemicals significant to life have mirror-image twins (left-handed and right-handed structures), a characteristic that is conventionally called chirality ... more

DKSH and Bruker AXS sign distribution agreement for Asia Pacific

20-Apr-2018 DKSH Business Unit Technology, a leading Market Expansion Services provider for technology companies seeking to grow their business in Asia, and Bruker AXS, a leading provider of Analytical X-ray Solutions, have signed a multi-product line distribution agreement for South Korea, Australia, ... more

Bruker acquires pioneering IR company

19-Apr-2018 Bruker announced that it has acquired Anasys Instruments Corp., a privately held company that develops and manufactures nanoscale infrared spectroscopy and thermal measurement instruments. This acquisition adds to Bruker’s portfolio of Raman and FTIR spectrometers, as well as to its nanosca ... more

'Tic-tac-toe'-themed MRI technology easy win for neurological disease researchers

17-Apr-2018 The University of Pittsburgh houses a whole-body 7 Tesla magnetic resonance imager (7T MRI), one of the strongest human MRI devices in the world and a powerful imaging tool that allows researchers to gain a far better understanding of brain structure and function. Tamer Ibrahim, associate p ... more

analytica closes with record-breaking visitor attendance

Most international analytica in history

16-Apr-2018 The 26th analytica met with overwhelming interest. In the past four days, some 35,800 visitors from all over the world came to the competitive exhibition of the industry on the Munich fairgrounds. They all wanted to know: Where is the laboratory industry heading? At the leading internationa ... more

All news on lab technology

Evotec and Celgene enter into strategic oncology partnership

22-May-2018 Evotec AG announced that Evotec and Celgene Corporation have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology. Evotec has built one of the industry's broadest and most innovative pre-clinical discovery and development pla ... more

Pierre Fabre and Roche extend collaboration agreement on companion diagnostic development

22-May-2018 Pierre Fabre announced today the extension of a collaboration agreement with Roche on companion diagnostic development for W0101, Pierre Fabre's new antibody drug conjugate (ADC) product candidate targeting Insulin-like Growth Factor 1 (IGF-1) receptor currently in the international Phase I ... more

PhoreMost completes $15M Series-A round to enter drug discovery

Investment to fund expansion of operations and progression of drug target pipeline

22-May-2018 PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has completed an £11m ($15m) Series-A investment round. The investment will be used to expand operations on the Babraham Research Campus and progress several novel drug ... more

Drug companies selling more 'lifestyle,' less 'symptom'

17-May-2018 Prescription drug commercials are getting longer and providing less factual information. A study finds that the majority of these ads focus on lifestyle improvements made post-medication rather than side-effects and the negative emotions associated with certain health issues. The team of r ... more

Study: Superbug MRSA infections less costly, but still deadly

17-May-2018 Staph infections, whether MRSA (resistant to methicillin) or susceptible, are important and deadly. Drug-resistant staph infections continue to be deadlier than those that are not resistant and treatable with traditional antibiotics, but treatment costs surprisingly are the same or slightly ... more

Enzyme's movement may be key to new cancer drugs

17-May-2018 Revealing all the steps required to activate an enzyme called a protein kinase may identify new ways to target cancer, according to new University of Arizona-led research. Not only must the kinase have all needed parts in place, the enzyme must move in the correct manner and at the correct ... more

Tumor-like spheres help scientists discover smarter cancer drugs

16-May-2018 Cancer is a disease often driven by mutations in genes. As researchers learn more about these genes, and the proteins they code for, they are seeking smarter drugs to target them. The ultimate goal is to find ways to stop cancer cells from multiplying out of control, thereby blocking the gr ... more

Trial shows chemotherapy is helping kids live with pulmonary vein stenosis

16-May-2018 Pulmonary vein stenosis (PVS) is a rare disease in which abnormal cells build up inside the veins responsible for carrying oxygen-rich blood from the lungs to the heart. It restricts blood flow through these vessels, eventually sealing them off entirely if left untreated. Typically affectin ... more

Combat the deadly gastrointestinal infection C. diff

16-May-2018 Researchers from the University of California, Irvine and Harvard University have discovered how the Clostridium difficile toxin B (TcdB) recognizes the human Frizzled protein, the receptor it uses to invade intestinal cells and lead to deadly gastrointestinal infections. The findings could ... more

Multi-drug resistant infections rising in children

14-May-2018 Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study. "Acinetobacter are bacteria known to cause serious infections and notoriously difficult ... more

All news on pharma

Metal-based probes for detection of dopamine receptors, a cancer biomarker

Discovery can be potentially developed as a novel early cancer detection technology

22-May-2018 A team led by Dr Edmond Ma Dik-lung, Associate Professor of the Department of Chemistry of Hong Kong Baptist University (HKBU) has developed the world's first iridium(III)-based probes for imaging dopamine receptors in living cells. The discovery has enhanced the understanding of dopamine r ... more

Merck and Washington University working on diagnostics and treatment of malnutrition

Genome editing to be used in intestinal bacteria research

22-May-2018 Merck announced a collaboration with Washington University in St. Louis, Missouri, USA, that could lead to the optimizing of nutritional supplements to restore a healthy gut microbial community (microbiome). The two-year collaboration will employ Merck’s CRISPR genome-editing technology in ... more

Drug companies selling more 'lifestyle,' less 'symptom'

17-May-2018 Prescription drug commercials are getting longer and providing less factual information. A study finds that the majority of these ads focus on lifestyle improvements made post-medication rather than side-effects and the negative emotions associated with certain health issues. The team of r ... more

Study: Superbug MRSA infections less costly, but still deadly

17-May-2018 Staph infections, whether MRSA (resistant to methicillin) or susceptible, are important and deadly. Drug-resistant staph infections continue to be deadlier than those that are not resistant and treatable with traditional antibiotics, but treatment costs surprisingly are the same or slightly ... more

Tumor-like spheres help scientists discover smarter cancer drugs

16-May-2018 Cancer is a disease often driven by mutations in genes. As researchers learn more about these genes, and the proteins they code for, they are seeking smarter drugs to target them. The ultimate goal is to find ways to stop cancer cells from multiplying out of control, thereby blocking the gr ... more

RNA molecules predict adverse heart growth and function that can lead to atrial fibrillation

16-May-2018 Researchers have identified that enlargement of the left atrium of the heart is linked to abnormal activity of molecules that are associated with adverse changes in the heart's size, shape, structure, and function -- conditions that can lead to atrial fibrillation and death. The new study, ... more

Taurine deficiency in sperm causes male infertility

16-May-2018 Sperm are highly specialized cells adapted to achieve a single goal: fertilize an egg. Along the road to fertilization sperm must embark on a lengthy journey to the female oviduct, avoiding several fatal stresses that occur when they pass through different physiological environments. Howeve ... more

Trial shows chemotherapy is helping kids live with pulmonary vein stenosis

16-May-2018 Pulmonary vein stenosis (PVS) is a rare disease in which abnormal cells build up inside the veins responsible for carrying oxygen-rich blood from the lungs to the heart. It restricts blood flow through these vessels, eventually sealing them off entirely if left untreated. Typically affectin ... more

Combat the deadly gastrointestinal infection C. diff

16-May-2018 Researchers from the University of California, Irvine and Harvard University have discovered how the Clostridium difficile toxin B (TcdB) recognizes the human Frizzled protein, the receptor it uses to invade intestinal cells and lead to deadly gastrointestinal infections. The findings could ... more

Dengue 'hot spots' provide map to chikungunya and Zika outbreaks

15-May-2018 Identifying dengue fever "hot spots" can provide a predictive map for outbreaks of chikungunya and Zika -- two other viral diseases that, along with dengue, are spread by the Aedes aegypti mosquito. The findings show the first confirmation of the spatial-temporal overlap for outbreaks of th ... more

All news on healthcare
News by department
  • Products

    PhoreMost completes $15M Series-A round to enter drug discovery

    Investment to fund expansion of operations and progression of drug target pipeline

    22-May-2018 PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has completed an £11m ($15m) Series-A investment round. The investment will be used to expand operations on the Babraham Research Campus and progress several novel drug ... more

    Miniature Cell Factory

    “B CUBE” spin-off paves the way to innovative therapies

    04-May-2018 Scientists from the start-up project denovoMATRIX at the B CUBE Center for Molecular Bioengineering at Technische Universität Dresden have developed a platform to create novel, tailor-made biomaterials for cell culture applications. Their vision is to enable the discovery of cell culture co ... more

    Merck to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group

    03-May-2018 Merck announced a development agreement for investigational molecule abituzumab with SFJ Pharmaceuticals Group (SFJ), a US-based company focused on increasing R&D output and productivity through innovative models. “Our collaboration with SFJ illustrates Merck’s increasing focus on strategic ... more

  • Business

    Pierre Fabre and Roche extend collaboration agreement on companion diagnostic development

    22-May-2018 Pierre Fabre announced today the extension of a collaboration agreement with Roche on companion diagnostic development for W0101, Pierre Fabre's new antibody drug conjugate (ADC) product candidate targeting Insulin-like Growth Factor 1 (IGF-1) receptor currently in the international Phase I ... more

    PhoreMost completes $15M Series-A round to enter drug discovery

    Investment to fund expansion of operations and progression of drug target pipeline

    22-May-2018 PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has completed an £11m ($15m) Series-A investment round. The investment will be used to expand operations on the Babraham Research Campus and progress several novel drug ... more

    Greiner Bio-One acquires 3D Cell Culture Technology assets from Nano3D Biosciences

    15-May-2018 Greiner Bio-One North America, Inc. has acquired 3D Cell Culture Technology previously owned by Nano 3D Biosciences, Inc. As an international distributor of these products since 2016, Greiner Bio-One has now taken the initiative to become a premier provider of this technology worldwide. Mag ... more

  • Price Development

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

    BASF increases prices for Vitamin E and A feed grade

    14-Nov-2013 BASF increases prices for Vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all Vitamin A products. Existing contractual obligations with customers will be honored. more

  • Research

    Metal-based probes for detection of dopamine receptors, a cancer biomarker

    Discovery can be potentially developed as a novel early cancer detection technology

    22-May-2018 A team led by Dr Edmond Ma Dik-lung, Associate Professor of the Department of Chemistry of Hong Kong Baptist University (HKBU) has developed the world's first iridium(III)-based probes for imaging dopamine receptors in living cells. The discovery has enhanced the understanding of dopamine r ... more

    Merck and Washington University working on diagnostics and treatment of malnutrition

    Genome editing to be used in intestinal bacteria research

    22-May-2018 Merck announced a collaboration with Washington University in St. Louis, Missouri, USA, that could lead to the optimizing of nutritional supplements to restore a healthy gut microbial community (microbiome). The two-year collaboration will employ Merck’s CRISPR genome-editing technology in ... more

    A new way to stimulate cellular recycling process

    18-May-2018 Brown University researchers studying the biology of aging have demonstrated a new strategy for stimulating autophagy, the process by which cells rebuild themselves by recycling their own worn-out parts. In a study the researchers show that the approach increased the lifespans of worms and ... more

  • People

    Horizon Discovery appoints new CEO

    11-May-2018 Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Group" or "the Company"), a global leader in gene editing and gene modulation technologies, is pleased to announce the appointment of Terry Pizzie as Chief Executive Officer and Board Director with immediate effect. Terry joined Horizo ... more

    CureVac Announces New Management Structure

    Founder Ingmar Hoerr to transition to Chairman role

    09-May-2018 CureVac AG announced that Founder and Chief Executive Officer, Dr. Ingmar Hoerr, intends to transition from his current CEO position to the Supervisory Board at the upcoming Annual General Meeting on June 20, 2018 and Hoerr stand for election as Chairman of the Supervisory Board afterwards. ... more

    Pharnext appoints Chief Operating Officer

    30-Apr-2018 Pharnext SA announced the appointment of Amit Kohli, a senior healthcare industry executive, as Chief Operating Officer (COO). Mr. Kohli is responsible for leading Pharnext's corporate strategy and operations. "Amit is a seasoned leader with over 20 years' experience in the healthcare indus ... more

  • Finances

    PhoreMost completes $15M Series-A round to enter drug discovery

    Investment to fund expansion of operations and progression of drug target pipeline

    22-May-2018 PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has completed an £11m ($15m) Series-A investment round. The investment will be used to expand operations on the Babraham Research Campus and progress several novel drug ... more

    ZEISS: High-Tech Drives Growth

    Medical technology and industrial metrology business still on track for growth

    18-May-2018 The first six months of fiscal year 2017/18 (ended 31 March 2018) were successful for the ZEISS Group and saw its revenue rise by 9 percent to EUR 2.773 billion (1st six months of 2016/17: EUR 2.550 billion), and as much as 13 percent after adjustments for currency effects. At EUR 380 milli ... more

    Eurofins acquires German pharma quality service company

    09-May-2018 Eurofins Scientific announces that it has signed an exclusive agreement to acquire PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH (“PHAST”), one of Europe’s leading service providers in the field of pharmaceutical products quality. The transaction is expected to close in the ... more

  • Cooperation

    Evotec and Celgene enter into strategic oncology partnership

    22-May-2018 Evotec AG announced that Evotec and Celgene Corporation have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology. Evotec has built one of the industry's broadest and most innovative pre-clinical discovery and development pla ... more

    Pierre Fabre and Roche extend collaboration agreement on companion diagnostic development

    22-May-2018 Pierre Fabre announced today the extension of a collaboration agreement with Roche on companion diagnostic development for W0101, Pierre Fabre's new antibody drug conjugate (ADC) product candidate targeting Insulin-like Growth Factor 1 (IGF-1) receptor currently in the international Phase I ... more

    Merck to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group

    03-May-2018 Merck announced a development agreement for investigational molecule abituzumab with SFJ Pharmaceuticals Group (SFJ), a US-based company focused on increasing R&D output and productivity through innovative models. “Our collaboration with SFJ illustrates Merck’s increasing focus on strategic ... more

  • Technology

    Metal-based probes for detection of dopamine receptors, a cancer biomarker

    Discovery can be potentially developed as a novel early cancer detection technology

    22-May-2018 A team led by Dr Edmond Ma Dik-lung, Associate Professor of the Department of Chemistry of Hong Kong Baptist University (HKBU) has developed the world's first iridium(III)-based probes for imaging dopamine receptors in living cells. The discovery has enhanced the understanding of dopamine r ... more

    Merck and Washington University working on diagnostics and treatment of malnutrition

    Genome editing to be used in intestinal bacteria research

    22-May-2018 Merck announced a collaboration with Washington University in St. Louis, Missouri, USA, that could lead to the optimizing of nutritional supplements to restore a healthy gut microbial community (microbiome). The two-year collaboration will employ Merck’s CRISPR genome-editing technology in ... more

    Tiny 'antenna' tweaked on cells

    18-May-2018 Scientists at Johns Hopkins Medicine and the National Tsing Hua University in Taiwan say they have found a fast way to manipulate a cell's cilia, the tiny, fingerlike protrusions that "feel" and sense their microscopic environment. The experiments, performed in mouse cells, may advance scie ... more

  • Laws

    Combined resistance to multiple antibiotics: A growing problem in the EU

    17-Nov-2017 On the occasion of the 10th European Antibiotic Awareness Day, the European Centre for Disease Prevention and Control (ECDC) is releasing its latest EU-wide data on antibiotic resistance, as well as its guidance on prevention and control of carbapenem-resistant Enterobacteriaceae (CRE). In ... more

    Focus on Medical Device Regulation

    BVMed, Earlybird, High-Tech Gründerfonds and BIOCOM publish “MedTech Radar 9”

    15-Nov-2017 The EU Medical Device Regulation heralds a new era for the medical technology sector: in future, any company wishing to bring medical devices to market must face the requirements of this new regulatory framework. This implies a sizeable challenge for the many small and medium-sized enterpri ... more

    EPA to Grant Merck’s Patent Application for CRISPR Technology

    Related patent application recently awarded in Australia

    04-Aug-2017 Merck announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells. The patent will provide Merck’s CRISPR genomic integration technolo ... more

  • Market

    Eurofins acquires German pharma quality service company

    09-May-2018 Eurofins Scientific announces that it has signed an exclusive agreement to acquire PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH (“PHAST”), one of Europe’s leading service providers in the field of pharmaceutical products quality. The transaction is expected to close in the ... more

    DKSH and Bruker AXS sign distribution agreement for Asia Pacific

    20-Apr-2018 DKSH Business Unit Technology, a leading Market Expansion Services provider for technology companies seeking to grow their business in Asia, and Bruker AXS, a leading provider of Analytical X-ray Solutions, have signed a multi-product line distribution agreement for South Korea, Australia, ... more

    Sanofi to invest €350 million in Canadian vaccine facility

    Toronto facility is one of the largest-ever investments by Sanofi in a single building

    13-Apr-2018 Sanofi is investing €350 million (CAD $500 million) for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. The investment bolsters the company’s Canadian operations and its commitment to advancing public ... more

  • Politics

    Multinational companies continue to produce unregulated antibiotics in India

    06-Feb-2018 Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle University. The research found that multinational companies continued to manufacture many unapproved formulations, despite pledging to tackle ... more

    cytena receives Dr. Rudolf-Eberle-Prize 2017

    Ministry of Economics recognizes cytena’s innovative energy

    01-Dec-2017 cytena was distinguished with the Innovation Award of Baden-Württemberg, one of the most economically powerful and competitive regions in Europe. Since 1985, the Ministry of Economics recognizes small and medium-sized enterprises for their innovative products, processes and services. The Mi ... more

    EMA to relocate to Amsterdam

    Working with Dutch government to ensure successful move by end of March 2019

    22-Nov-2017 The European Medicines Agency (EMA) will relocate to Amsterdam in the Netherlands. This decision was taken today by the EU 27 Member States in the margins of the General Affairs Council (Art.50). The Agency now has just over 16 months to prepare for the move and take up its operations in Am ... more

  • Manufacturing

    PlasmidFactory expands lab capacities

    30-Apr-2018 PlasmidFactory GmbH & Co. KG announces that it has acquired new laboratory space for research and development as well as for the highly documented production of plasmid DNA, and has begun reconstructing and equipping the same. "New capabilities are the key to helping our customers move to c ... more

    Sanofi to invest €350 million in Canadian vaccine facility

    Toronto facility is one of the largest-ever investments by Sanofi in a single building

    13-Apr-2018 Sanofi is investing €350 million (CAD $500 million) for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. The investment bolsters the company’s Canadian operations and its commitment to advancing public ... more

    Lonza opens world's largest cell and gene therapy facility

    Manufacturing plant in Texas exeeds 25,000 square meters

    10-Apr-2018 Lonza today is opening the world’s largest dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies – the next era in medicine – and with the mission of enabling them to deliver these types of treatments to pat ... more

  • Career

    Systematic analysis of data from animal models reveals opportunities and limitations

    Professor Malcolm Macleod awarded the BfR’s Maria Sibylla Merian Fellowship

    18-Apr-2018 What opportunities and what limits result from the use of laboratory animals in the preclinical and clinical research? Neurologist Malcolm Macleod has dedicated himself to this topic. For his interdisciplinary research work and his contribution to improving animal welfare, he is awarded thi ... more

    Sartorius Stedim supports biotech training at U Penn

    17-Apr-2018 Sartorius Stedim Biotech andPenn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders. Part o ... more

    Michael Schreiber becomes second Managing Director of LUMITOS

    The internationally experienced marketing executive joins LUMITOS from Mettler-Toledo

    06-Apr-2018 As of 1 April, Michael Schreiber co-heads the Berlin-based company LUMITOS. The marketing expert with a natural science PhD joins Stefan Knecht as a second Managing Director of Europe's market-leading provider of B2B portals in the chemical, life science, lab equipment, pharmaceutical, anal ... more

Organizations in the news
News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE